News Sentiment

ANNX sentiment intelligence

Annexin Pharmaceuticals AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 2 relevant articles
Exchange STO Sweden
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 12.90 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 2

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-0.8% over one week, +4.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

The subscription period in Annexin Pharmaceuticals’ rights issue begins today

Market Reaction

Balanced read

46/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction -0.8% Price digesting
Trend fit Trend inactive 4.9% over four weeks
Fair value -60.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 2
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 2
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 2

Event Lens

What the news is about

Classified themes
Market update 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-2 of 2